Posterior reversible encephalopathy syndrome (PRES) associates various neurological manifestations (headaches, seizures, altered mental status, cortical blindness, focal neurological deficits, vomiting) and transient changes on neuroimaging consistent with cerebral edema. Posterior reversible encephalopathy syndrome mainly occurs in the setting of hypertension, eclampsia, renal failure and/or use of immunosuppressive drugs.
We report four cases of PRES complicating systemic lupus erythematosus (SLE). In all our cases, renal involvement and hypertension were present. Neurological symptoms were typical. Magnetic resonance imaging showed posterior cerebral edema and in one case hemorrhagic complication. With symptomatic treatment and immunosuppressor withdrawal when they were previously used, symptoms fully resolved within 15 days in all cases, but one who had only partial regression related to cerebral hemorrhage.
Including our cases, we reviewed a total of 46 patients with SLE and PRES. Their clinical and radiological presentation was not specific. The peculiar role of SLE itself in the occurrence of PRES was not clear, since hypertension (95%), renal involvement (91%), recent onset of immunosuppressive drugs (54%) and/or recent treatment with high intravenous dose of steroids (43%) were often present. The hypertension and other worsening factors should be treated. Finally, the evolution of this clinical and radiological spectacular syndrome is generally rapidly favorable. Lupus (2008) 17, 139—147.
Casey SO, Sampaio RC, Michel E., Truwit CLPosterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol2000; 21: 1199—1206.
2.
Hinchey J., Chaves C., Appignani B. et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med1996; 334: 494—500.
3.
Bell CL, Partington C., Robbins M., Graziano F., Turski P., Kornguth S.Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum1991; 34: 432—441.
4.
Caminal-Montero L., Trapiella-Martinez L., Suarez-Casado H., Garcia-Garcia J.Reversible posterior leucoencephalopathy in systemic lupus. Med Clin (Barc)2005; 125: 719.
5.
Cassano G., Gongora V., Zunino A., Roverano S., Paira S.Reversible posterior leukoencephalopathy in systemic lupus erythematosus with thrombotic thrombocytopenic purpura. J Clin Rheumatol2007; 13: 55—57.
6.
Casali-Rey JI , Davalos EG, Lopez-Amalfara A., Julio-Munoz D., Pagano MAPosterior reversible encephalopathy syndrome: some case reports. Rev Neurol2003; 37: 224—227.
7.
Foocharoen C. , Tiamkao S., Srinakarin J., Chamadol N., Sawanyawisuth K.Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus . J Med Assoc Thai2006; 89: 1029—1032.
8.
Gocmen R., Ozgen B., Oguz KKWidening the spectrum of PRES: Series from a tertiary care center. Eur J Radiol2007; 62: 454—9.
9.
Kur JK, Esdaile JMPosterior Reversible Encephalopathy Syndrome- An Underrecognized Manifestation of Systemic Lupus Erythematosus. J Rheumatol2006; 33: 2178—2183.
10.
Lateef A., Lim AYCase reports of transient loss of vision and systemic lupus erythematosus . Ann Acad Med Singapore2007; 36: 146—144.
11.
Magnano MD, Bush TM, Herrera I., Altman RDReversible posterior leukoencephalopathy in patients with systemic lupus erythematosus . Semin Arthritis Rheum2006; 35: 396—402.
12.
Mavragani CP , Vlachoyiannopoulos PG, Kosmas N., Boletis I., Tzioufas AG, Voulgarelis M.A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion . Rheumatology (Oxford)2004; 43: 1450—1451.
13.
Mukherjee P. , McKinstry RCReversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology2001; 219: 756—765.
14.
Ozyurek H., Oguz G., Ozen S. et al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol2005; 20: 990—993.
15.
Pavlakis SG , Frank Y., Kalina P., Chandra M., Lu D.Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol1997; 16: 145—148.
16.
Prasad N., Gulati S., Gupta RK, Kumar R., Sharma K., Sharma RKIs reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol2003; 18: 1161—1166.
17.
Primavera A. , Audenino D., Mavilio N., Cocito L.Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis2001; 60: 534—537.
18.
Schwartz RB , Jones KM, Kalina P. et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases . AJR Am J Roentgenol1992; 159: 379—383.
19.
Sheth RD, Riggs JE, Bodenstenier JB, Gutierrez AR, Ketonen LM, Ortiz OAParietal occipital edema in hypertensive encephalopathy: a pathogenic mechanism . Eur Neurol1996; 36: 25—28.
20.
Shin KC, Choi HJ, Bae YD, Lee JC, Lee EB, Song YWReversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol2005; 11: 164—166.
21.
Thaipisuttikul I., Phanthumchinda K.Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus . J Neurol2005; 252: 230—231.
22.
Yong PF, Hamour SM, Burns A.Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant2003; 18: 2660—2662.
23.
Punaro M., Abou-Jaoude P., Cimaz R., Ranchin B.Unusual neurologic manifestations (II): posterior reversible encephalopathy syndrome (PRES) in the context of juvenile systemic lupus erythematosus. Lupus2007; 16: 576—579.
24.
Dy GK, Swaroop VS31-year-old woman with confusion and labile behavior. Mayo Clin Proc2002; 77: 557—560.
25.
Ishimori ML , Pressman BD, Wallace DJ, Weisman MHPosterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus2007 ; 16: 436—443.
26.
Ozgencil E. , Gulucu C., Yalcyn S. et al. Seizures and loss of vision in a patient with systemic lupus erythematosus. Neth J Med2007; 65: 274.
27.
Schwartz RB , Mulkern RV, Gudbjartsson H., Jolesz F.Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol1998; 19: 859—862.
28.
Schwartz RB , Feske SK, Polak JF et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology2000; 217: 371—376.
29.
Servillo G. , Bifulco F., De Robertis E. et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med2007; 33: 230—236.
30.
Lamy C., Oppenheim C., Meder JF, Mas JLNeuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging2004; 14: 89—96.
Bartynski WS , Boardman JF, Zeigler ZR, Shadduck RK, Lister J.Posterior reversible encephalopathy syndrome in infection, sepsis, and shock . AJNR Am J Neuroradiol2006; 27: 2179—2190.
33.
Giorgi D., David V., Afeltra, A.Gabrieli CBTransient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome. Ocul Immunol Inflamm2001; 9: 49—57.
34.
Calabrese LH , Molloy ES, Huang D., Ransohoff RMProgressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease . Arthritis Rheum2007; 56: 2116—2128.
35.
Ay H., Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology1998; 51: 1369—1376.
